These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15192786)

  • 21. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma.
    Ura K; Obama K; Satoh S; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2006 Nov; 12(22):6611-6. PubMed ID: 17121879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Chen F; Li S; Castranova V
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1320-1. PubMed ID: 19826380
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular pathogenesis of intrahepatic cholangiocarcinoma.
    Andersen JB
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):101-13. PubMed ID: 25174625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New concept: cellular senescence in pathophysiology of cholangiocarcinoma.
    Sasaki M; Nakanuma Y
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):625-38. PubMed ID: 26680649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
    Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
    Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation and tumor progression: a lesson from TNF-alpha-dependent FAK signaling in cholangiocarcinoma.
    Mon NN; Kokuryo T; Hamaguchi M
    Methods Mol Biol; 2009; 512():279-93. PubMed ID: 19347283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEACAM6 gene expression in intrahepatic cholangiocarcinoma.
    Ieta K; Tanaka F; Utsunomiya T; Kuwano H; Mori M
    Br J Cancer; 2006 Aug; 95(4):532-40. PubMed ID: 16868542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
    Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of DPC4/Smad4 gene in stone-containing intrahepatic bile duct.
    Lee KT; Chang WT; Wang SN; Chuang SC; Chai CY; Hu SW
    J Surg Oncol; 2006 Sep; 94(4):338-43. PubMed ID: 16917866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of a human cholangiocarcinoma cell line.
    Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
    Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of differentially expressed proteins in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.
    Pak JH; Moon JH; Hwang SJ; Cho SH; Seo SB; Kim TS
    J Cell Biochem; 2009 Dec; 108(6):1376-88. PubMed ID: 19798681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
    Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.